The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period.
Tag:- Transdermal drug delivery systems market
MarketsandMarkets™ - Aug 25, 2021
Transdermal Drug Delivery Systems Market worth $7.1 billion by 2023
MarketsandMarkets™ - Jun 08, 2021
The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period (2018-2023).
Transdermal Drug Delivery System Market - Major Revenue Growth is Expected in Near Future
MarketsandMarkets™ - Jun 07, 2021
The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period (2018-2023).
Hisamitsu Pharmaceuticals, Mylan and Novartis are leading players in Transdermal Drug Delivery Systems Market
MarketsandMarkets™ - Apr 02, 2021
Transdermal Drug Delivery Systems Market worth $7.1 billion by 2023
MarketsandMarkets™ - Sep 10, 2019